Clinical Trial Update: Safety, Tolerability and Efficacy of Switching From Talipexole to Pramipexole in Patients With Parkinson's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating safety, tolerability and efficacy of switching from talipexole to pramipexole in Parkinson disease. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Pramipexole (pramipexole)
• Talipexole (talipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Parkinson Disease | Phase 4 | Status: COMPLETED